Qualitative study into quality of life issues surrounding insulin pump use in Type 1 diabetes

Currently, there is a need for qualitative research about how insulin pump therapy changes quality of life, which is significant to people with type 1 diabetes. This study aimed to elicit the experiences of current insulin pump users in order to discover the therapy\u27s benefits, downsides and effect on their quality of life. A qualitative approach was taken in order to reveal subjective experiences. This research will inform future research and assist with policy and guideline development by health care providers about pump therapy. Participants were briefly interviewed by telephone about their experiences of living with an insulin pump. Four questions were asked. These covered the benefits of pump use, effects on quality of life, whether participants experienced downsides to using a pump and any other issues participants wished to raise. In all, 80 insulin pump users participated in the study. All 80 reported experiencing benefits; insulin pump use had improved their quality of life. Key positive themes emerging from the data included greater control (45), flexibility (33), freedom (28), family effects (seven), convenience (seven) and independence (five). Key drawbacks emerging from the data included visibility— device (25), breakdown (17), visibility— skin (five) and cost (three). Participants overwhelmingly reported experiencing benefits and improvements in their quality of life associated with insulin pump use. These pump users remain on pump therapy by choice, so the benefits clearly outweigh the downsides. However, further work needs to determine if these downsides contribute to explaining why 2–4% of pump users discontinue pump use after a short period of time, or whether this is a result of other factors. Copyright © 2007 John Wiley & Sons

Qualitative study into quality of life issues surrounding insulin pump use in Type 1 diabetes

Currently, there is a need for qualitative research about how insulin pump therapy changes quality of life, which is significant to people with type 1 diabetes. This study aimed to elicit the experiences of current insulin pump users in order to discover the therapy\u27s benefits, downsides and effect on their quality of life. A qualitative approach was taken in order to reveal subjective experiences. This research will inform future research and assist with policy and guideline development by health care providers about pump therapy. Participants were briefly interviewed by telephone about their experiences of living with an insulin pump. Four questions were asked. These covered the benefits of pump use, effects on quality of life, whether participants experienced downsides to using a pump and any other issues participants wished to raise. In all, 80 insulin pump users participated in the study. All 80 reported experiencing benefits; insulin pump use had improved their quality of life. Key positive themes emerging from the data included greater control (45), flexibility (33), freedom (28), family effects (seven), convenience (seven) and independence (five). Key drawbacks emerging from the data included visibility— device (25), breakdown (17), visibility— skin (five) and cost (three). Participants overwhelmingly reported experiencing benefits and improvements in their quality of life associated with insulin pump use. These pump users remain on pump therapy by choice, so the benefits clearly outweigh the downsides. However, further work needs to determine if these downsides contribute to explaining why 2–4% of pump users discontinue pump use after a short period of time, or whether this is a result of other factors. Copyright © 2007 John Wiley & Sons

Unrealistic pessimism about risk of Coronary Heart Disease and stroke in patients with type 2 diabetes

OBJECTIVE: We examined the accuracy of type 2 diabetes (T2D) patients risk estimates of developing Coronary Heart Disease (CHD)/ having a stroke as a consequence of diabetes and their mood about these risks. METHODS: Patients reported their perceived risks of developing CHD/ having a stroke and rated their mood about these risks using a self-report measure. Using an objective risk calculator, they were then told their actual risk of CHD and stroke and their mood was re-assessed. RESULTS: Patients estimates of their risk of CHD / stroke were grossly inflated. A negative relationship between disease risk and mood was also seen where higher risk of actual and perceived CHD/stroke was related to worse mood. A positive relationship between mood and extent of perceptual error was further observed; the more inaccurate patients perceptions of CHD/stroke risk were, the better their mood. Mood improved after patients were given accurate risk information. CONCLUSION: T2D patients are unrealistically pessimistic about their risk of developing CHD/ stroke. These risks and the extent of perceptual risk error are associated with mood, which improves upon providing patients with accurate risk information about CHD / stroke. PRACTICE IMPLICATIONS: These results have implications for the routine communication of risk to T2D patients